Disease Landscape and Forecast Insights
Comprehensive market intelligence and actionable insights help you optimize your long-term disease strategy
Report
August 26, 2016
Schizophrenia | Unmet Need | Cognitive Impairment Associated with Schizophrenia | US/EU | 2016
Decision Resources Group (DRG) estimates that 80% of the more than 3 million diagnosed prevalent cases of schizophrenia within our surveyed markets (i.e., United States, France, Germany, and United…
Report
October 10, 2014
Beyond Positive Symptoms: How Receptive Are U.S. Psychiatrists and Payers to Therapies Targeting Negative or Cognitive Symptoms of Schizophrenia? | Physician & Payer Forum | US | 2014
Schizophrenia is an often disabling psychiatric disease whose core treatment consists of up to a lifetime of treatment with antipsychotics (older typical antipsychotics or newer atypical…
Report
August 21, 2014
Healthcare Reform and Behavioral Health: Impact of Health Exchanges and Medicaid Expansion on Prescribing for Schizophrenia, Major Depression, and Bipolar Disorder | Physician & Payer Forum | US | 2014
The Affordable Care Act has expanded access to insurance coverage to millions and has reformed health insurance requirements to assure more-comprehensive coverage of behavioral health and…
